Program at a Glance
- 현재 페이지 경로
> Program > Program at a Glance
- Scientific Session [Boehringer Ingelheim/Lilly]
- New Horizons in Treatment of Heart Failure
- Apr. 22 (Sat.) 12:15-12:55, Rm.214
- Chairpersons: Myung Ho Jeong, Seok Min Kang
-
12:15 - 12:30
-
Empagliflozin’s WIN Against a Formidable Foe, "Heart Failure with Preserved Ejection Fraction"
[Speaker] Jaewon Oh / Yonsei Univ., Korea
-
12:30 - 12:45
-
Should Empagliflozin Be Used Against Chronic Heart Failure Regardless of LVEF?
[Speaker] Jae Yeong Cho / Chonnam National Univ., Korea
-
12:45 - 12:55
-
Discussion
- The Korean Society of Cardiology
-
101-1704, Lotte Castle President, 109, Mapo-daero, Mapo-gu, Seoul, 04146, Republic of Korea
Copyright© The Korean Society of Cardiology. All rights reserved.
